📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Erratum: Lentiviral vectors can be used for full-length dystrophin gene therapy. (2017)

First Author: Counsell JR

Attributed to: MICA: Development of gene therapy for the incurable inherited childhood epilepsy, Dravet Syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/srep46880

PubMed Identifier: 28849794

Publication URI: http://europepmc.org/abstract/MED/28849794

Type: Journal Article/Review

Volume: 7

Parent Publication: Scientific reports

ISSN: 2045-2322